dr. ghosh on safety results from the phase 2 pilot trial in non-hodgkin lymphoma
Published 4 years ago • 65 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
1:05
dr. ghosh on efficacy results from the phase 2 pilot trial in non-hodgkin lymphoma
-
1:50
dr. ghosh on pet-adapted therapy in patients with hodgkin lymphoma
-
0:53
dr. ghosh on frontline immunotherapy in hodgkin lymphoma
-
1:39
dr. ghosh on global trials with zanubrutinib in mcl and nhl
-
2:08
dr. ghosh on the benefits of lisocabtagene maraleucel in relapsed/refractory nhl
-
1:56
safety and efficacy of plamotamab in the treatment of non-hodgkin lymphoma subtypes
-
0:45
i've survived cancer 3 times! robyn's non-hodgkin lymphoma story
-
28:55
what does the future hold for advanced stage hodgkin's lymphoma?
-
2:03
long-term follow-up results from the zuma-1 trial in non-hodgkin lymphoma
-
1:34
dr. ghosh on the need to develop novel therapies in dlbcl
-
1:19
dr. brody on safety profile of in-situ vaccines in indolent non-hodgkin lymphoma
-
7:16
dose-escalation of mosunetuzumab with polatuzumab vedotin for r/r b-cell non-hodgkin’s lymphoma
-
25:04
doctor undergoes car t-cell therapy clinical trial (non-hodgkin lymphoma) | robyn’s story (3 of 3)
-
2:33
updates from a phase i clinical trial examining ublituximab in combination with tgr-1202
-
50:00
non-hodgkin lymphoma | martin hutchings, md, phd
-
10:23
an expert guide to non-hodgkin's lymphoma - online interview
-
7:19
expanding the role of car t in non-hodgkin lymphoma
-
1:59:00
lymphoma committee
-
0:57
acceptable safety observed with frontline brentuximab vedotin combo in hl